Anti‐IgE mAb (omalizumab) vs usual care
Exacerbations · autumn asthma exacerbations in children
Omalizumab probably leads to lower exacerbations compared with usual care (moderate certainty).
3 findings from 1 review
- OR 0.48 [0.25, 0.92]1 study · 348 participantsModerate
- OR 0.37 [0.17, 0.81]1 study · 184 participantsModerate
- OR 0.63 [0.22, 1.79]1 study · 164 participantsModerate